Amgen, Inc. (AMGN)
313.83
-7.40
(-2.30%)
USD |
NASDAQ |
Dec 09, 16:00
314.25
+0.42
(+0.13%)
After-Hours: 18:56
Amgen Total Assets (Quarterly): 90.14B for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Biogen, Inc. | 29.21B |
| Gilead Sciences, Inc. | 58.53B |
| Johnson & Johnson | 192.82B |
| Eli Lilly & Co. | 114.94B |
| Regeneron Pharmaceuticals, Inc. | 40.17B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 80.52B |
| Shareholders Equity (Quarterly) | 9.619B |
| Debt to Equity Ratio | 5.675 |
| Current Ratio | 1.280 |
| Net Debt Paydown Yield | 1.06% |